ES2556253B2 - Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis - Google Patents

Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis Download PDF

Info

Publication number
ES2556253B2
ES2556253B2 ES201531001A ES201531001A ES2556253B2 ES 2556253 B2 ES2556253 B2 ES 2556253B2 ES 201531001 A ES201531001 A ES 201531001A ES 201531001 A ES201531001 A ES 201531001A ES 2556253 B2 ES2556253 B2 ES 2556253B2
Authority
ES
Spain
Prior art keywords
local
antifungal preparations
onychomycosis
preparations intended
onychomycosis treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201531001A
Other languages
English (en)
Spanish (es)
Other versions
ES2556253A2 (es
ES2556253R1 (es
Inventor
Pascal VIANT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R&D PHARMA
Original Assignee
R&D PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R&D PHARMA filed Critical R&D PHARMA
Publication of ES2556253A2 publication Critical patent/ES2556253A2/es
Publication of ES2556253R1 publication Critical patent/ES2556253R1/es
Application granted granted Critical
Publication of ES2556253B2 publication Critical patent/ES2556253B2/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES201531001A 2014-07-11 2015-07-10 Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis Expired - Fee Related ES2556253B2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1401569A FR3023484B1 (fr) 2014-07-11 2014-07-11 Preparations antifongiques destinees au traitement local des onychomycoses
FR140156 2014-07-11

Publications (3)

Publication Number Publication Date
ES2556253A2 ES2556253A2 (es) 2016-01-14
ES2556253R1 ES2556253R1 (es) 2016-02-02
ES2556253B2 true ES2556253B2 (es) 2016-09-19

Family

ID=52358801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201531001A Expired - Fee Related ES2556253B2 (es) 2014-07-11 2015-07-10 Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis

Country Status (3)

Country Link
CH (1) CH709877B1 (fr)
ES (1) ES2556253B2 (fr)
FR (1) FR3023484B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6800209B2 (ja) 2015-08-13 2020-12-16 ビーエイエスエフ・ソシエタス・エウロパエアBasf Se 水溶性溶媒、無機増粘剤及びアルコキシレートを含む非水性殺有害生物剤懸濁液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672078A (en) * 1985-07-03 1987-06-09 Schering-Plough Corporation Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
US5487776A (en) * 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
US6197098B1 (en) * 1999-12-16 2001-03-06 Isp Investments Inc. Fast drying biocidal preservative composition
MXPA03004049A (es) * 2003-05-08 2004-11-10 Acosta Rita Guadal Escorihuela Composicion topica para el tratamiento de micosis en las unas y procedimiento de obtencion.
WO2010091045A2 (fr) * 2009-02-05 2010-08-12 Advanced Technology Materials, Inc. Composition ne contenant pas de fluorure pour l'élimination de polymères et autres matières organiques à partir d'une surface
RU2601896C2 (ru) * 2013-04-30 2016-11-10 Закрытое Акционерное Общество "Вертекс" Комбинированный препарат для лечения грибковых заболеваний ногтей

Also Published As

Publication number Publication date
FR3023484A1 (fr) 2016-01-15
ES2556253A2 (es) 2016-01-14
ES2556253R1 (es) 2016-02-02
CH709877A2 (fr) 2016-01-15
CH709877B1 (fr) 2019-04-30
FR3023484B1 (fr) 2018-10-12

Similar Documents

Publication Publication Date Title
CL2021001575A1 (es) Pirazolopirimidinas sustituidas y purinas sustituidas y su uso como inhibidores de proteasa procesadora específica de ubiquitina 1 (usp1)
CL2020002512A1 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak.
CL2019001674A1 (es) Inhibidores de imidazopirazina de tirosina quinasa de bruton.
MX2018011102A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos.
CL2019001079A1 (es) Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina.
CL2013003227A1 (es) “compuestos derivados de indazol sustituidos, moduladores de la actividad de proteínas quinasas; proceso de obtención de ellos; método in vitro para inhibir proteínas quinasas; composición y combinación farmacéutica que los comprende; y su uso en el tratamiento del cáncer" pct
BR112018014281A2 (pt) agentes, usos e métodos para o tratamento da sinucleinopatia
UY33346A (es) Compuestos y metodos para la modulacion de quinasa e indicaciones de la misma
PE20161032A1 (es) Anticuerpos anti-tau(ps422) humanizados y metodos de utilizacion
BR112016018205A8 (pt) métodos de tratamento de mal de alzheimer, de seleção de pacientes, de identificação de pacientes, de previsão, de otimização da eficácia terapêutica, kit, uso de agente e uso in vitro de agente
UY36561A (es) Nuevas proteínas específicas para pioverdina y pioquelina
UY32030A (es) "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
ECSP13012436A (es) ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
GT201300080A (es) Proceso de elaboracion para derivados de pirimidina
BR112017022526A2 (pt) uso de uma composição de tratamento capilar
BR112016002287A2 (pt) compostos terapeuticamente ativos e seus métodos de uso
AR092188A1 (es) ANTICUERPOS HUMANOS PARA GFRa3 Y METODOS PARA SU USO
AR092899A1 (es) Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion
ES2525137B1 (es) Agentes para tratar el mieloma múltiple
CO2020009524A2 (es) Formulación de adenovirus del grupo b
MX2019010707A (es) Metodos para tratar y/o prevenir queratosis actinica.
BR112018011851A2 (pt) compostos de isoindol
EA201992562A1 (ru) Пептиды для лечения сахарного диабета
EA201390287A1 (ru) Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии
CO2024000581A2 (es) Comprimido que comprende una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2556253

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20160919

FD2A Announcement of lapse in spain

Effective date: 20250826